Showing 141 - 160 results of 282 for search '"brain tumor"', query time: 0.06s Refine Results
  1. 141

    Multiple Extracranial Metastases from Primary Gliosarcoma in a Patient with Two Previous Different Primary Cancers by T. Capion, J. Hauerberg, H. Broholm, A. Muhic

    Published 2019-01-01
    “…Gliosarcoma (GS) constitutes a minor fraction of primary glioblastoma (GBM), which is the most frequent malignant brain tumor in adults. Despite the fact that malignant gliomas are highly invasive, extracranial metastases are very rarely seen, and the mechanisms behind extracranial dissemination are still unclarified. …”
    Get full text
    Article
  2. 142
  3. 143

    Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders by Keren Zhou, Ligen Shi, Yan Wang, Sheng Chen, Jianmin Zhang

    Published 2016-01-01
    “…In addition, we summarize the recent researches on the role of NLRP3 inflammasome in central nervous system (CNS) diseases, including traumatic brain injury, ischemic stroke and hemorrhagic stroke, brain tumor, neurodegenerative diseases, and other CNS diseases. …”
    Get full text
    Article
  4. 144

    New Immunotherapeutic Approaches for Glioblastoma by Gustavo Ignacio Vázquez Cervantes, Dinora F. González Esquivel, Saúl Gómez-Manzo, Benjamín Pineda, Verónica Pérez de la Cruz

    Published 2021-01-01
    “…Glioblastoma (GBM) is the most common primary malignant brain tumor with a high mortality rate. The current treatment consists of surgical resection, radiation, and chemotherapy; however, the median survival rate is only 12–18 months despite these alternatives, highlighting the urgent need to find new strategies. …”
    Get full text
    Article
  5. 145

    Advancements in the Use of Hydrogels for Regenerative Medicine: Properties and Biomedical Applications by Andrea Revete, Andrea Aparicio, Bruno A. Cisterna, Javier Revete, Luis Luis, Ernesto Ibarra, Edwin A. Segura González, Jay Molino, Diego Reginensi

    Published 2022-01-01
    “…Hydrogels represent a potential alternative to regenerating tissue lost after removing a brain tumor and/or brain injuries. This reason presents them as an exciting alternative to highly complex human physiological problems, such as injuries to the central nervous system and neurodegenerative disease.…”
    Get full text
    Article
  6. 146

    Glioblastoma. Past, present and future by Adriel Herrero Díaz, Luis Manuel Abreu Pereira, Ilian Esteban Tarife Romero, Diana Rosa González Tamayo

    Published 2024-07-01
    “…<p>Glioblastoma is the most advanced, common and malignant stage of primary brain tumors in adults. It represents about 57% of all glial tumors. …”
    Get full text
    Article
  7. 147

    Gene Therapy for Glioblastoma Multiforme by Smit Shah, Joshua Green, Shantelle A. Graff, Qi Li, John D. Heiss

    Published 2025-01-01
    “…Glioblastoma multiforme (GBM) is a devastating, aggressive primary brain tumor with poor patient outcomes and a five-year survival of less than 10%. …”
    Get full text
    Article
  8. 148

    Glioblastoma Multiforme Stem Cells by Irena Dimov, Deasanka Tasic-Dimov, Irena Conic, Vladisav Stefanovic

    Published 2011-01-01
    “…Glioblastoma multiforme (GBM) is an aggressive, malignant, and lethal brain tumor, resistant to all current forms of treatment. …”
    Get full text
    Article
  9. 149

    Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models by Andrea Mancini, Alessandro Colapietro, Loredana Cristiano, Alessandra Rossetti, Vincenzo Mattei, Giovanni Luca Gravina, Giovanni Luca Gravina, Héctor Perez-Montoyo, Marc Yeste-Velasco, Jose Alfon, Carles Domenech, Claudio Festuccia

    Published 2022-11-01
    “…BackgroundGlioblastoma multiforme (GBM) is the most malignant adult brain tumor. Current standard of care treatments have very limited efficacy, being the patients´ overall survival 14 months and the 2-year survival rate less than 10%. …”
    Get full text
    Article
  10. 150

    Comparative analysis of pediatric SHH medulloblastoma DAOY spheres and adherent monolayers: implications for medulloblastoma research by Jana Klementová, Šárka Jarošová, Irina Danilová, Markéta Farníková, Josef Novotný, Marie Davídková, Martina Zíková

    Published 2025-01-01
    “…Abstract Medulloblastoma, the most prevalent brain tumor among children, requires a comprehensive understanding of its cellular characteristics for effective research and treatment. …”
    Get full text
    Article
  11. 151

    Toxic Epidermal Necrolysis Associated with Antiepileptic Drugs and Cranial Radiation Therapy by Shereen Elazzazy, Taghrid Abu Hassan, Ashraf El Seid, Cicy Mary Jacob

    Published 2013-01-01
    “…Although TEN is a rare toxicity, physicians should pay a special attention to the monitoring of brain tumor patients on antiepileptic prophylaxis during cranial irradiation; furthermore, patients should be counselled to notify their physicians if they develop any new or unusual symptoms.…”
    Get full text
    Article
  12. 152

    Glioma Stem Cells: Signaling, Microenvironment, and Therapy by Brandon D. Liebelt, Takashi Shingu, Xin Zhou, Jiangong Ren, Seul A. Shin, Jian Hu

    Published 2016-01-01
    “…Glioblastoma remains the most common and devastating primary brain tumor despite maximal therapy with surgery, chemotherapy, and radiation. …”
    Get full text
    Article
  13. 153

    Brain gliomas new transcriptomic discoveries from differentially expressed genes to therapeutic targets by Shiwen Pei, Zhiquan Jiang, Hongwei Cheng

    Published 2025-01-01
    “…Abstract Gliomas are a prevalent form of primary malignant brain tumor, yet the intricate molecular mechanisms underlying its pathogenesis remain unclear. …”
    Get full text
    Article
  14. 154

    PLIN1 suppresses glioma progression through regulating lipid metabolism by Kui Luo, Kai Zhuang, Hao Wu, Yuanbing Chen, Yi Liu, Fan Yang, Zhifei Wang

    Published 2025-01-01
    “…Abstract Glioma is a common and destructive brain tumor, which is highly heterogeneous with poor prognosis. …”
    Get full text
    Article
  15. 155

    Brain Midline Shift Measurement and Its Automation: A Review of Techniques and Algorithms by Chun-Chih Liao, Ya-Fang Chen, Furen Xiao

    Published 2018-01-01
    “…Shift of midline intracranial structures helps diagnosing intracranial lesions, especially traumatic brain injury, stroke, brain tumor, and abscess. Being a sign of increased intracranial pressure, MLS is also an indicator of reduced brain perfusion caused by an intracranial mass or mass effect. …”
    Get full text
    Article
  16. 156

    Brain CT image classification based on mask RCNN and attention mechanism by Shoulin Yin, Hang Li, Lin Teng, Asif Ali Laghari, Ahmad Almadhor, Michal Gregus, Gabriel Avelino Sampedro

    Published 2024-11-01
    “…The application of machine learning, and block-chain techniques into medical image retrieval, classification and auxiliary diagnosis has become one of the research hotspots at present. Brain tumor is one of the major diseases threatening human life. …”
    Get full text
    Article
  17. 157

    LncRNA-PVT1 enhances glucose metabolism of pediatric low-grade glioma cells through sponging miR-187-3p by Beibei Li, Zijian Feng, Yanyan Zheng

    Published 2024-12-01
    “…Studies have revealed critical roles of long non-coding RNAs (lncRNAs) in brain tumor progressions. Here, we aimed to investigate the clinical roles and molecular mechanisms of lncRNA PVT1 in PLGG. …”
    Get full text
    Article
  18. 158

    Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated by Malcolm F. McDonald, Sricharan Gopakumar, Tareq A. Juratli, Ilker Y. Eyüpoglu, Ganesh Rao, Jacob J. Mandel, Ali Jalali

    Published 2025-01-01
    “…Abstract Glioblastoma is the deadliest primary brain tumor, largely due to inevitable recurrence of the disease after treatment. …”
    Get full text
    Article
  19. 159

    Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma by Ren Y, Yang H, Xu D, Zhang Z, Gao S, Yu R

    Published 2025-01-01
    “…Yanhong Ren,1,2,&ast; Han Yang,3,&ast; Duo Xu,4 Zhengkui Zhang,4 Shangfeng Gao,1,4 Rutong Yu1,4 1Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China; 2Beijing Institute of Brain Disorders, Capital Medical University, Beijing, 100069, People’s Republic of China; 3Department of Neurology, The First Hospital of Changsha, Changsha, 410008, People’s Republic of China; 4Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Shangfeng Gao; Rutong Yu, Email gaoshangfeng@xzhmu.edu.cn; rtyu@xzhmu.edu.cnAbstract: Glioma is the most common primary malignant brain tumor with a poor survival rate. It is characterized by diffuse and invasive growth and heterogeneity, which limits tumor identification and complete resection. …”
    Get full text
    Article
  20. 160

    Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma by Hongbing Cheng, Xiao Meng, Yanhua Zhang, Pu Wang, Yucheng Lu

    Published 2025-01-01
    “…Abstract Low-grade glioma (LGG) is a primary, slow-growing brain tumor; however, its treatment and prognosis remain challenging. …”
    Get full text
    Article